UNSPSC 51431601: Anipamil

This classification denotes a calcium channel blocker, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9Y54WZV1CJ. European Medicines Agency schedules Anipamil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05516MIG. Anipamil generally arises in the molecular formula C34H52N2O2.

UNSPSC 51431601 Anipamil is a Commodity code that covers advanced cardiac and emergency life-support pharmaceutical products purchased by municipal fire and rescue services. The City of Tampa's Fire Rescue Department is currently soliciting sealed bids for a suite of advanced life support medications including epinephrine, diltiazem, adenosine, and labetalol — medications administered by paramedics and emergency medical technicians during acute cardiac events and hemodynamic emergencies. State and local fire departments and emergency medical services agencies are the primary buyers under this code; municipal purchasing offices issue solicitations on their behalf, typically using sealed-bid (IFB) vehicles for standardized pharmaceutical procurement.

The Tampa Fire Rescue solicitation (IFB 26P00188, due April 8, 2026) represents current activity in Florida and signals demand in states with large municipal fire services. The procurement specifies firm pricing inclusive of freight, delivery within ten calendar days, nine-month minimum shelf life, full-year warranty, and expired-inventory replacement — all common terms in emergency pharmaceutical supply chains. The estimated contract value is $40,000.00. The City of Tampa designated the opportunity as sheltered for Small Local Business Enterprises (SLBEs) with a 5 percent bid discount not to exceed $10,000 and required vendors to submit VPAT accessibility documentation, OSHA Safety Data Sheets, and subcontractor intent forms for SLBE participation. The contract term runs one year from award with two optional one-year renewals and unilateral extension rights for up to three 30-day periods.